News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celsus Therapeutics Closes $12.5 Million Private Placement



10/1/2013 9:27:19 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK and LONDON, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Celsus Therapeutics (OTCQB:CLSXY), an emerging growth, development-stage biopharmaceutical company, announced today that it has closed a previously announced securities purchase agreement for a private placement financing with a select group of institutional healthcare investors. With the closing of the transaction, Celsus will receive gross proceeds of approximately $12.5 million from the sale of 21,958,302 ordinary shares at a price of $0.57 per share.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES